Andrew Clark is a Managing Partner of Leavitt Equity Partners and has been with the fund since its inception in 2014. From its beginning, Andrew has led the diligence teams for all deal activity and transaction closings, totaling 30+ successful closings and over 200+ due diligence processes. Additionally, he has managed most of the internal back-office operations for LEP, serves on the compliance committee, manages Limited Partner relationships (fundraising and reporting), works closely with key Partner Funds and portfolio investments, and serves as a Board Member or Board Observer on several Fund I and Fund II companies.

Andrew originally joined Leavitt Partners in 2010 and worked directly with Leavitt Partners’ private equity clients to evaluate investment opportunities, identify new market segments, and make investment decisions in healthcare markets. Including leading Leavitt Partners’ participation in ReposiTrak, TAV Health, OFSG, and ProLung / IONIQ Sciences. Prior to joining Leavitt Partners, Andrew spent 3+ years as a case manager consultant for Investor Group Services, LLC in Boston, Massachusetts (a former Ernst & Young business). There he provided M&A and Transaction Advisory Solutions to private equity funds and their portfolio companies, including financial and economic modeling, as well as market sizing and segmentation, and company performance. Andrew advised PE and Corporate M&A clients on over 50 transactions during this period, including several healthcare deals. Before his time at Investor Group Services, Andrew was a financial analyst at Zions Bancorporation, working directly under CEO Harris Simmons where he provided analytical support to several areas of the bank. Andrew also spent time in Santiago Chile working with a boutique investment bank, ASSET Chile.

Andrew earned a bachelor’s degree in economics from Harvard College, where he was a member of the winning 2001 Ivy League Championship football team. He also earned his MBA from the Harvard Business School.